Biothera (United States)

Recent papers from Biothera (United States)

1. Breast Cancer Index and Recommendations for Extended Endocrine TherapyJAMA Network Open · 2026
2. Impact of the Breast Cancer Index on extended endocrine therapy recommendations in patients from the BCI Registry study.Journal of Clinical Oncology · 2026
3. Identifying premenopausal patients with early-stage hormone receptor–positive breast cancer at minimal risk of distant recurrence by breast cancer indexSHILAP Revista de lepidopterología · 2026
4. Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer IndexJAMA Network Open · 2025
5. Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown PrimaryJCO Precision Oncology · 2024
6. Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast CancerJAMA Oncology · 2024
7. Clinical and pathological characteristics of cancer of unknown primary with renal profile using gene expression profiling (GEP)–based cancer classification.Journal of Clinical Oncology · 2024
8. Breast Cancer Index re-stratifies 21-gene assay risk groups for late distant recurrence and extended endocrine therapy benefit: Results from the BCI Registry Study.Journal of Clinical Oncology · 2024
9. Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry StudyJournal of the National Comprehensive Cancer Network · 2024
10. The Ethics of Genetic Testing for Inherited Cancer-Predisposing GenesJournal of the Advanced Practitioner in Oncology · 2024
11. Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 TrialClinical Cancer Research · 2024
12. Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM TrialClinical Cancer Research · 2024
13. Inadequate Uptake of USPSTF-Recommended Low Dose CT Lung Cancer ScreeningJournal of Primary Care & Community Health · 2024
14. Altered plasma metabolite levels can be detected years before a glioma diagnosisJCI Insight · 2023
15. Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom studyBreast Cancer Research · 2022
16. Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor AntibodiesFrontiers in Oncology · 2022
17. Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine PhosphorylaseFrontiers in Bioengineering and Biotechnology · 2021
18. Arginine depletion as a therapeutic approach for patients with COVID-19International Journal of Infectious Diseases · 2020
19. Molecular Drivers of Onco type DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC StudyJournal of Clinical Oncology · 2020
20. A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological RolesCancers · 2020